Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
Prophylactic vaccination against infectious diseases is one of the most successful public health measures of our lifetime. More recently, therapeutic vaccination against established diseases such as cancer has proven to be more challenging. In the host, cancer cells evade immunologic regulation by m...
Main Authors: | Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon, Anna M. Eiring, Shrikanth S. Gadad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/5/816 |
Similar Items
-
Challenges and New Directions in Therapeutic Cancer Vaccine Development
by: Danjie Pan, et al.
Published: (2024-11-01) -
Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria
by: Raja Veerapandian, et al.
Published: (2024-05-01) -
Personalized vaccination against ovarian cancer: what are the possibilities?
by: Janos L. Tanyi, et al.
Published: (2018-11-01) -
Evolution of Cancer Vaccines—Challenges, Achievements, and Future Directions
by: Ban Qi Tay, et al.
Published: (2021-05-01) -
EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
by: A. B. Dorzhieva, et al.
Published: (2021-10-01)